An in-depth look to KOREA PHARMA CO., LTD. operating, investing, and financing activities

032300 free cash flow for Q2 24 is 1.52 B KRW. For 2023, 032300 free cash flow was 3.29 B KRW and operating cash flow was 4.82 B KRW.